Revenue, 2025
USD 365.57 Bn
Forecast Year, 2035
USD 1,365.20
CAGR, 2025 - 2035
14.08%
Report Coverage
Worldwide
The global Immunomodulators Market, valued at USD 365.57 billion in 2025, is projected to surge to USD 1,365.20 billion by 2035, growing at a robust CAGR of 14.08%, driven by rising autoimmune disorders and expanding therapeutic applications.
Immunomodulators Market Size Analysis
Immunomodulators Market Size By Product 2025 to 2034 (USD Billion)
| Product | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Immunosuppressants | 0.82 | 0.96 | 1.10 | 1.27 | 1.47 | 1.70 | 1.96 | 2.27 | 2.64 | 3.04 |
| Immunostimulants | 1.66 | 1.91 | 2.21 | 2.55 | 2.94 | 3.39 | 3.91 | 4.52 | 5.19 | 6.01 |
Immunomodulators Market Size By Application 2025 to 2034 (USD Billion)
| Application | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Oncology | 0.25 | 0.29 | 0.33 | 0.38 | 0.45 | 0.51 | 0.59 | 0.68 | 0.80 | 0.91 |
| Respiratory | 0.50 | 0.57 | 0.66 | 0.77 | 0.88 | 1.02 | 1.18 | 1.36 | 1.56 | 1.81 |
| HIV | 0.74 | 0.86 | 0.99 | 1.15 | 1.32 | 1.52 | 1.76 | 2.03 | 2.35 | 2.71 |
| Others | 0.99 | 1.14 | 1.32 | 1.52 | 1.76 | 2.03 | 2.35 | 2.72 | 3.13 | 3.62 |
Immunomodulators Market Size By Region 2025 to 2034 (USD Billion)
| Region | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| North America | 0.25 | 0.29 | 0.33 | 0.39 | 0.44 | 0.51 | 0.59 | 0.69 | 0.79 | 0.91 |
| LAMEA | 0.50 | 0.57 | 0.66 | 0.77 | 0.88 | 1.02 | 1.18 | 1.35 | 1.57 | 1.82 |
| Europe | 0.74 | 0.86 | 0.99 | 1.14 | 1.32 | 1.53 | 1.76 | 2.04 | 2.35 | 2.71 |
| Asia-Pacific | 0.99 | 1.14 | 1.32 | 1.52 | 1.76 | 2.03 | 2.35 | 2.71 | 3.13 | 3.62 |
Immunomodulators Market Size to Hit USD 1,365.20 Billion by 2035
The global Immunomodulators Market size surpassed USD 365.57 billion in 2025 and is predicted to reach around USD 1,365.20 billion by 2035 with a registering a CAGR of 14.08%.
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com